DUBLIN–(BUSINESS WIRE)–The “Microcarrier Market by Equipment (SUB, SSB, Cell Counter, Filtration), Consumables (Media, Reagent), Microcarrier (Cationic, Collagen), Application (Vaccine, Cell & Gene Therapy), End User (Pharma, Biopharma, CROs, CMOs) – Global Forecast to 2026” report has been added to ResearchAndMarkets.com’s offering.
The microcarriers market is projected to reach USD 2.9 billion by 2026 from USD 1.7 billion in 2021, at a CAGR of 10.7% during the forecast period.
Increasing use of single-use bioreactors for bioprocessing, rising investment in R&D for development of vaccines and therapeutic proteins, and increasing government funding for cell and gene therapy.
The major factors driving the growth of the microcarriers market are rising demand for cell-based vaccines, technological advancements, and the availability of government funding and venture capital investments for cell and gene research. The growing preference for single-use technologies is an important trend and driver for the market.
However, the high cost of